NWBO   $0.28  1.23% Market Closed

Northwest Biotherapeutics Inc
Total Cash 2.88M
totalCashPerShare 0.002
EBITDA -60.47M
Total Debt 55.57M
quickRatio 0.051
currentRatio 0.089
Total Revenue 1.65M
debtToEquity
Revenue/Share 0.001
ROA -1.3716
ROE
grossProfits
freeCashflow -37.45M
operatingCashflow -59.48M
earningsGrowth
revenueGrowth 1.537
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -34.24314
profitMargins 0.0
enterpriseValue 443.21M
forwardPE
floatShares 1.14B
sharesOutstanding 1.25B
sharesShort 14.14M
sharesShortPriorMonth 13.83M
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.09%
heldPercentInstitutions 0.00%
Short Ratio help_outline 13.54%
shortPercentOfFloat 0.15%
impliedSharesOutstanding
bookValue -0.062
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -75.55M
trailingEps -0.07%
forwardEps
enterpriseToEbitda -7.33
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 13
lastUpdated Oct. 21, 2024, 1:28 p.m.